Futures Waver Ahead of Labor Data 📉

[Image](www.elitetrade.club) Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Happy Friday! It's January 6th. I hope you have a great weekend. Let's get ready to trade! Markets 📈 US benchmarks posted losses on Thursday after stronger-than-expected labor market data raised fears of more interest rate hikes to come. The S&P 500 fell 1.1%, and the Dow lost 1.0%. The Nasdaq underperformed with a 1.4% decline, and the small-cap Russell 2K sank 1.0%. This morning, futures are wavering in anticipation of today's December jobs report. S&P 500 futures are currently flirting with losses. Sponsored [Apple's EV Could Send this Tiny Stock to the Moon 🚀]( An Apple EV is coming, and it could change transportation as we know it. And while I don’t think it’s a bad idea to swipe up some Apple stocks right now... There’s a better under-the-radar opportunity... This $5 stock has potential to 40X once the Apple Car goes live. [Get All the Details Here]( Premarket Highlights 🔎 ⚪ None What to Watch Today 👀 Jobs Report Yesterday's jobless claims report came in unexpectedly strong, but the news sent stocks lower because investors believe strength in the labor market increases the likelihood of more rate hikes in the months ahead. The Fed has been clear that it's not slowing down rate increases until inflation is tamed, but the market seems to throw a fit whenever there's talk of further increases. Today's jobs report will likely send stocks lower if it surpasses consensus estimates. Major Earnings 💰 Greenbrier Companies, Inc. (The) [GBX] ... AM Economy 🏗 - December Jobs Report - ISM services index [Dec] ... 10a - Factory orders [Nov] ... 10a - Core equipment orders [Nov] ... 10a Running Hot 🔥 Gainers - Myomo [MYO] >> +33.2% - AMTD Digital [HKD] >> +60.1% - Jianzhi Centrury Technology [JZ] >> +26.5% Decliners - Graphite Bio [GRPH] >> (46.7%) - Fate Therapeutics [FATE] >> (51.5%) - ATAI Life Sciences [ATAI] >> (39.1%) World Wrestling Entertainment [WWE] - Last Close: $72.04 The Wall Street rumor mill is boosting shares of WWE. The Wall Street Journal reported Thursday that the pro wrestling company is exploring a potential sale. There are also rumors that former chief executive, Vince McMahon, plans to return to the company. McMahon reportedly wrote a letter to WWE expressing his desire to return to the company and lead its strategic review process. The board rejected the request to return to the company, but said it was willing to work with McMahon on the strategic review. WWE is up 10.7% in light of the premarket rumors. My Take: It sounds like WWE is aggressively pursuing a potential deal. If they make one, shares could soar in the weeks ahead. This could be a "buy the rumor" opportunity. CytomX Therapeutics [CTMX] - Last Close: $1.79 CytomX Therapeutics has a powerful new ally. The oncology-focused biotech announced a collaboration with Moderna [MRNA] to develop investigational mRNA-based therapies early this morning. CytomX will receive $35 million upfront under the terms of the deal, plus up to $1.2 billion in potential milestone payments. The company will also be eligible to receive tiered royalties based on global net sales of any products commercialized under the agreement. Moderna will also have the option to participate in future equity financing in CytomX, subject to certain conditions. CTMX is one of the morning's top performers with a 78.2% gain on active volume. My Take: CMTX just landed itself a deep-pocketed ally, and this bodes well for the business's long-term survivability. Shares are beginning to up-trend, and it's possible the stock's downward move may have bottomed out. Spruce Biosciences [SPRB] - Last Close: $1.25 Spruce Bio is soaring after announcing a big deal. The tiny biotech stock entered into an exclusive licensing agreement with Kaken Pharmaceuticals for developing Spruce's tildacerfont in Japan. Spruce will receive an upfront payment of $15 million to licenses the therapy, which is being developed as a treatment for congenital adrenal hyperplasia. Spruce can also receive additional milestones and double-digit tiered royalties on net sales in Japan. Kaken will be responsible for development & commercialization of the drug in the Japanese market, and it has the right to first negotiation to expand the deal to other Asian markets. News of the deal made SPRB one of the morning's top movers with a 76.8% gain, and it's one of the most active stocks in the premarket. My Take: This is a solid deal for SPRB, but most of the good news is probably priced into this stock already. Shares have been trending higher lately, but be wary of a potential pullback. Biocept [BIOC] - Last Close: $0.5601 An early morning announcement is boosting shares of Biocept. Today, the molecular oncology diagnostics company announced plans to explore strategic alternatives to enhance shareholder value. Biocept is exploring an acquisition, merger, reverse merger, other business combination, sales of assets, licensing and other strategic transactions. The company says it doesn't intend to make further disclosures about the review unless the Board approves a specific measure. Biocept also said it will slash its staff by about 35% in order to extend and maximize its resources, and it ended the year with a $13 million cash balance. BIOC is up 16.0% on news of the effort to build shareholder value and spare the company from potential bankruptcy. My Take: This company is in a tough spot, but it could break out if it manages to make a deal. However, a bankruptcy filling will almost certainly send shares lower. This could be an opportunity for a speculative trade. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( P.P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](